BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19165115)

  • 1. Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients: preliminary report of an open trial.
    Jung SI; Seo CH; Jang K; Ham BJ; Choi IG; Kim JH; Lee BC
    J Burn Care Res; 2009; 30(2):257-60; discussion 261. PubMed ID: 19165115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory vulvovaginal pruritus with naltrexone, a specific opiate antagonist.
    Böttcher B; Wildt L
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():115-6. PubMed ID: 24388844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone for the management of post-burn pruritus: A preliminary report.
    LaSalle L; Rachelska G; Nedelec B
    Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of refractory aquagenic pruritus with naltrexone.
    Ingber S; Cohen PD
    J Cutan Med Surg; 2005 Oct; 9(5):215-6. PubMed ID: 16502200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
    Chang Y; Golkar L
    Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA; Kolawole BA; Udoh SJ
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist.
    Metze D; Reimann S; Luger TA
    Ann N Y Acad Sci; 1999 Oct; 885():430-2. PubMed ID: 10816681
    [No Abstract]   [Full Text] [Related]  

  • 11. Pruritus responsive to naltrexone in a patient with cholestatic liver disease.
    Mozer-Glassberg Y; Hojsak I; Zevit N; Shapiro R; Shamir R
    Isr Med Assoc J; 2011 Feb; 13(2):111-2. PubMed ID: 21443039
    [No Abstract]   [Full Text] [Related]  

  • 12. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.
    Pauli-Magnus C; Mikus G; Alscher DM; Kirschner T; Nagel W; Gugeler N; Risler T; Berger ED; Kuhlmann U; Mettang T
    J Am Soc Nephrol; 2000 Mar; 11(3):514-519. PubMed ID: 10703675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone: a case report of pruritus from an antipruritic.
    Sullivan JR; Watson A
    Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of pruritus characteristics and impact on burn survivors.
    Parnell LK; Nedelec B; Rachelska G; LaSalle L
    J Burn Care Res; 2012; 33(3):407-18. PubMed ID: 22210065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone.
    Chia BK; Tey HL
    J Drugs Dermatol; 2014 Dec; 13(12):1440. PubMed ID: 25607785
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis.
    Monroe EW
    J Am Acad Dermatol; 1989 Jul; 21(1):135-6. PubMed ID: 2745760
    [No Abstract]   [Full Text] [Related]  

  • 17. Pruritus in adult burn survivors: postburn prevalence and risk factors associated with increased intensity.
    Carrougher GJ; Martinez EM; McMullen KS; Fauerbach JA; Holavanahalli RK; Herndon DN; Wiechman SA; Engrav LH; Gibran NS
    J Burn Care Res; 2013; 34(1):94-101. PubMed ID: 23079565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itching for relief.
    Health News; 1999 Dec; 5(15):6. PubMed ID: 10633587
    [No Abstract]   [Full Text] [Related]  

  • 19. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease.
    Kumar N; Garg N; Bailey A
    J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised crossover trial of naltrexone in uraemic pruritus.
    Peer G; Kivity S; Agami O; Fireman E; Silverberg D; Blum M; laina A
    Lancet; 1996 Dec; 348(9041):1552-4. PubMed ID: 8950882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.